Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Are the Real HCV Infection Features in Iranian Patients the Same As What Is Expected?
  6. Scopus by Title (Ref)

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection

- Jalilian S. , et al.

2. Random effect model for identifying related factors to virological response in HCV patients

- Zayeri F. , et al.

3. Application of zero-inflated poisson mixed models in prognostic factors of hepatitis C

- Akbarzadeh Baghban A. , et al.

4. Statistical count models for prognosis the risk factors of hepatitis C

- Pourhoseingholi A. , et al.

5. High rate of virological response to peginterferon α-2a-ribavirin among non-cirrhotic Iranian hemophilia patients with chronic hepatitis C

- Moghaddam M.A. , et al.

6. IL28B polymorphism, explanation for Different Responses to Therapy in Hepatitis C Patients

- Sharafi H. , et al.

7. Virus-triggered autophagy in viral hepatitis - Possible novel strategies for drug development

- Alavian S.M. , et al.

8. Il28b SNP genotyping among Iranian HCV-infected patients: A preliminary report

- Mahboobi N. , et al.

9. IL28B polymorphism, explanation for different responses to therapy in hepatitis C patients

- Sharafi H. , et al.

10. Identification of HCV genotypes in HCV infected blood donors

- Sharifi Z. , et al.

11. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin

- Alavian S.M. , et al.

12. Reply from the author

- Ayyub M. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.